This study investigated the effects of hydrocortisone therapy on patients with septic shock. It found no significant difference in 28-day mortality between patients given hydrocortisone and those given placebo. While hydrocortisone hastened the reversal of shock, it also increased risks of superinfection and hyperglycemia. Based on these results, hydrocortisone cannot be recommended as general therapy for septic shock patients.